Westlake Chemical Partners LP (WLKP)
NYSE: WLKP · Real-Time Price · USD
22.82
+0.29 (1.29%)
At close: Apr 28, 2026, 4:00 PM EDT
22.72
-0.10 (-0.44%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Company Description
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States.
It’s ethylene production facilities which primarily convert ethane into ethylene. The company also sells ethylene co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis.
It serves as the general partner of the company. Westlake Chemical Partners LP was founded in 1991 and is headquartered in Houston, Texas.
Westlake Chemical Partners LP
| Country | United States |
| Founded | 2014 |
| IPO Date | Jul 30, 2014 |
| Industry | Chemicals |
| Sector | Materials |
| CEO | Jean-Marc Gilson |
Contact Details
Address: 2801 Post Oak Boulevard, Suite 600 Houston, Texas 77056 United States | |
| Phone | 713 585 2900 |
| Website | wlkpartners.com |
Stock Details
| Ticker Symbol | WLKP |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001604665 |
| CUSIP Number | 960417103 |
| ISIN Number | US9604171036 |
| Employer ID | 32-0436529 |
| SIC Code | 2860 |
Key Executives
| Name | Position |
|---|---|
| Jean-Marc Gilson | President, Chief Executive Officer and Director of Westlake Chemical Partners GP LLC |
| Mark Steven Bender CPA | Executive Vice President, Chief Financial Officer and Director of Westlake Chemical Partners GP LLC |
| Albert Yuan Chao | Executive Chairman of the Board Westlake Chemical Partners GP LLC |
| Jeffrey A. Holy | Vice President and Chief Accounting Officer of Westlake Chemical Partners GP LLC |
| L. Benjamin Ederington J.D. | Executive Vice President of Legal and External Affairs and Director of Westlake Chemical Partners GP LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 20, 2026 | 8-K | Current Report |
| Mar 11, 2026 | EFFECT | Notice of Effectiveness |
| Mar 9, 2026 | UPLOAD | Filing |
| Mar 4, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 4, 2026 | 10-K | Annual Report |
| Feb 24, 2026 | 8-K | Current Report |
| Feb 23, 2026 | 8-K | Current Report |
| Feb 17, 2026 | SCHEDULE 13G | Filing |
| Oct 31, 2025 | 10-Q | Quarterly Report |
| Oct 30, 2025 | 8-K | Current Report |